Completed PHASE4 INTERVENTIONAL 1-arm NCT02681510

UW-CTRI Triple Medication Smoking Cessation Study

UW-CTRI Smoking Cessation Medication Tolerability Study

Sponsor: University of Wisconsin, Madison

Conditions Smoking

Interventions Nicotine Mini Nicotine Transdermal Patch Varenicline

Updated 7 times since 2017 Last updated: Sep 13, 2017 Started: Feb 29, 2016 Primary completion: Jun 13, 2016 Completion: Jun 13, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02681510, this PHASE4 trial focuses on Smoking and remains completed. Sponsored by University of Wisconsin, Madison, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Oct 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Mar 2017 — Oct 2017 [monthly]

Active Not Recruiting PHASE4
Jan 2017 — Mar 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Wisconsin, Madison

Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madison, United States